Continued 5 alpha-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS Article

International Collaboration

author list

  • Kearns, James T.; Faino, Anna, V; Schenk, Jeanette M.; Newcomb, Lisa F.; Brooks, James D.; Carroll, Peter R.; Dash, Atreya; Ellis, William J.; Fabrizio, Michael; Gleave, Martin E.; Morgan, Todd M.; Nelson, Peter S.; Thompson, Ian M.; Wagner, Andrew; Zheng, Yingye; Lin, Daniel W.

publication date

  • January 1, 2019


published in



  • 5-alpha reductase inhibitors
  • adverse effects
  • diagnosis
  • prostatic neoplasms
  • watchful waiting

start page

  • 106

end page

  • 111


  • 201


  • 1